These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8858392)

  • 1. Compliance to longterm vasoactive intracavernous therapy.
    Pagliarulo A; Ludovico GM; Cirillo-Marucco E; Corvasce A; Pagliarulo G
    Int J Impot Res; 1996 Jun; 8(2):63-4. PubMed ID: 8858392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term experiences with autoinjection therapy of papaverine in erectile dysfunction].
    Jantos C; Krause W; Kauss E; Weidner W
    Urologe A; 1988 Jan; 27(1):18-21. PubMed ID: 3363769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
    Hayashi S; Iwai Y; Yasumoto R; Matsuda J; Kawano M; Omachi T; Kono T; Yamamoto S; Sakakura T; Minami H
    Hinyokika Kiyo; 1994 Jan; 40(1):37-41. PubMed ID: 7509119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term results of the treatment with intracavernous injection of vasoactive drugs].
    Rodríguez Vela L; Gonzalvo Ibarra A; Gil Martínez P; Benejan Gual J; Cuesta Presedo JM; Ríoja Sanz LA
    Arch Esp Urol; 1996 Apr; 49(3):257-69. PubMed ID: 8702347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow up outcome of intracavernous papaverine.
    al-Juburi AZ; O'Donnell PD
    J Ark Med Soc; 1990 Mar; 86(10):383-5. PubMed ID: 2138146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
    Perimenis P; Konstantinopoulos A; Perimeni PP; Gyftopoulos K; Kartsanis G; Liatsikos E; Athanasopoulos A
    Asian J Androl; 2006 Mar; 8(2):219-24. PubMed ID: 16491275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
    de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Our experience with pharmacological erection treatment of erectile dysfunction.
    Hattat H; Ozkara H; Akkus E; Alici B
    J Androl; 1994; 15 Suppl():47S-49S. PubMed ID: 7721677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracavernous injection of papaverine, phentolamine and phenoxybenzamine.
    Pettirossi O; Serenelli G
    Acta Urol Belg; 1988; 56(2):211-9. PubMed ID: 3400527
    [No Abstract]   [Full Text] [Related]  

  • 11. Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
    Israilov S; Niv E; Livne PM; Shmueli J; Engelstein D; Segenreich E; Baniel J
    Int J Impot Res; 2002 Feb; 14(1):38-43. PubMed ID: 11896476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy of erectile dysfunction using papaverine--2 1/2 years' experience].
    Schnyder von Wartensee M; Sieber A; Studer UE
    Schweiz Med Wochenschr; 1988 Jul; 118(30):1099-103. PubMed ID: 3175561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
    Raina R; Lakin MM; Agarwal A; Ausmundson S; Montague DK; Zippe CD
    Urology; 2004 Mar; 63(3):532-7; discussion 538. PubMed ID: 15028452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intracavernous self-injection in impotence].
    Sieber A; Schnyder von Wartensee M; Thönen HJ; Studer UE
    Ther Umsch; 1992 Jan; 49(1):49-55. PubMed ID: 1736402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intracavernous pharmacotherapy.
    Sidi AA
    Urol Clin North Am; 1988 Feb; 15(1):95-101. PubMed ID: 2449756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current role of intracavernous therapy in the treatment of erectile dysfunction].
    Asuar Aydillo S
    Arch Esp Urol; 2002 Jun; 55(5):475-82. PubMed ID: 12174413
    [No Abstract]   [Full Text] [Related]  

  • 17. Import catheter in erectile dysfunction.
    Kayigil O; Atahan O; Metin A
    J Urol; 1997 Aug; 158(2):530-2. PubMed ID: 9224341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of organic impotence. Self-administered intracavernous injection of papaverin HCI (a preliminary report)].
    Takamura T; Hashimoto H; Miyata M; Nakata Y; Osanai H; Yachiku S
    Hinyokika Kiyo; 1985 Jan; 31(1):97-9. PubMed ID: 3993499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self intra-cavernous injections as a successful treatment in pure neurogenic impotence.
    Greco E; Balbi PP; Virag R
    Riv Neurol; 1991; 61(1):35-8. PubMed ID: 1857921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reasons for high drop-out rate with self-injection therapy for impotence.
    Weiss JN; Badlani GH; Ravalli R; Brettschneider N
    Int J Impot Res; 1994 Sep; 6(3):171-4. PubMed ID: 7735362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.